Healthcare provider profile · identity verified

Prabhas Gupta, MD

Internal Medicine · SACRAMENTO, CA · NPI 1275976037

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	249	77
Pantoprazole Sodium	Pantoprazole Sodium	207	69
Rosuvastatin Calcium	Rosuvastatin Calcium	191	65
Atorvastatin Calcium	Atorvastatin Calcium	182	51
Levothyroxine Sodium	Levothyroxine Sodium	181	53
Ezetimibe	Ezetimibe	153	45
Jardiance	Empagliflozin	146	46
Tresiba Flextouch U-100	Insulin Degludec	137	42
Metformin Hcl Er	Metformin Hcl	132	43
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	130	20
Tamsulosin Hcl	Tamsulosin Hcl	118	38
Gabapentin	Gabapentin	107	36
Allopurinol	Allopurinol	92	26
Metoprolol Succinate	Metoprolol Succinate	90	25
Humalog Kwikpen U-100	Insulin Lispro	87	30
Celecoxib	Celecoxib	86	32
Spironolactone	Spironolactone	82	26
Telmisartan	Telmisartan	81	28
Ozempic	Semaglutide	80	22
Glipizide Er	Glipizide	73	22
Olmesartan Medoxomil	Olmesartan Medoxomil	73	24
Pregabalin	Pregabalin	72	22
Furosemide	Furosemide	70	28
Quetiapine Fumarate	Quetiapine Fumarate	69	20
Hydroxyzine Hcl	Hydroxyzine Hcl	65	30
Montelukast Sodium	Montelukast Sodium	65	22
Pravastatin Sodium	Pravastatin Sodium	65	18
Lisinopril	Lisinopril	64	18
Losartan Potassium	Losartan Potassium	63	17
Valacyclovir	Valacyclovir Hcl	61	23
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	60	26
Fenofibrate	Fenofibrate Nanocrystallized	59	22
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	53	17
Synjardy Xr	Empagliflozin/Metformin Hcl	51	14
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	50	17
Zolpidem Tartrate	Zolpidem Tartrate	50	suppressed
Trulicity	Dulaglutide	49	13
Clopidogrel	Clopidogrel Bisulfate	48	12
Mirtazapine	Mirtazapine	45	20
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	45	19
Albuterol Sulfate Hfa	Albuterol Sulfate	43	25
Duloxetine Hcl	Duloxetine Hcl	43	15
Potassium Chloride	Potassium Chloride	43	21
Ibuprofen	Ibuprofen	42	17
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	41	17
Atenolol	Atenolol	40	15
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	40	25
Imiquimod	Imiquimod	40	36
Finasteride	Finasteride	39	14
Diclofenac Sodium	Diclofenac Sodium	37	17
Escitalopram Oxalate	Escitalopram Oxalate	36	11
Omeprazole	Omeprazole	36	suppressed
Simvastatin	Simvastatin	36	suppressed
Baclofen	Baclofen	33	17
Buspirone Hcl	Buspirone Hcl	33	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	14
Methylprednisolone	Methylprednisolone	33	28
Valsartan	Valsartan	33	suppressed
Vascepa	Icosapent Ethyl	33	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	32	suppressed
Clonazepam	Clonazepam	32	suppressed
Sertraline Hcl	Sertraline Hcl	32	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	32	14
Azithromycin	Azithromycin	30	29
Januvia	Sitagliptin Phosphate	30	13
Lorazepam	Lorazepam	28	12
Meloxicam	Meloxicam	28	12
Mupirocin	Mupirocin	28	24
Nortriptyline Hcl	Nortriptyline Hcl	28	12
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Tizanidine Hcl	Tizanidine Hcl	27	12
Breyna	Budesonide/Formoterol Fumarate	26	suppressed
Carvedilol	Carvedilol	26	suppressed
Tresiba Flextouch U-200	Insulin Degludec	26	suppressed
Trospium Chloride Er	Trospium Chloride	26	11
Cephalexin	Cephalexin	25	21
Fluticasone Propionate	Fluticasone Propionate	25	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	19
Doxycycline Hyclate	Doxycycline Hyclate	24	23
Fluconazole	Fluconazole	24	20
Solifenacin Succinate	Solifenacin Succinate	24	11
Benazepril Hcl	Benazepril Hcl	23	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	23	suppressed
Topiramate	Topiramate	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	suppressed
Famotidine	Famotidine	22	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	20	suppressed
Novolog Flexpen	Insulin Aspart	20	11
Rybelsus	Semaglutide	20	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	18
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Diazepam	Diazepam	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Metformin Hcl	Metformin Hcl	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Trazodone Hcl	Trazodone Hcl	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Alprazolam	Alprazolam	17	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Nystatin	Nystatin	17	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	16	suppressed
Fluorouracil	Fluorouracil	16	13
Tramadol Hcl	Tramadol Hcl	16	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	15	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	15	suppressed
Bumetanide	Bumetanide	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	13
Synthroid	Levothyroxine Sodium	15	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	14	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Icosapent Ethyl	Icosapent Ethyl	14	suppressed
Lactulose	Lactulose	14	12
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Ciclopirox	Ciclopirox	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	11
Estradiol	Estradiol	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Insulin Degludec Pen (U-200)	Insulin Degludec	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Clindamycin Hcl	Clindamycin Hcl	11	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	11	suppressed
Linzess	Linaclotide	11	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Megestrol Acetate	Megestrol Acetate	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Tradjenta	Linagliptin	11	suppressed
Ursodiol	Ursodiol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error